Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 6/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ACLY | P53396 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15512157 | 1.00 | ALDH1A1 (0.50) | ALDH1A1ACHEGPR84FFAR1FFAR4 | |
| SCHEMBL1550224 | 1.00 | ALDH1A1 (0.50) | ALDH1A1ACHEGPR84FFAR1FFAR4 | |
| SCHEMBL3799843 | 1.00 | ALDH1A1 (0.50) | ALDH1A1ACHEGPR84FFAR1FFAR4 | |
| SCHEMBL15512661 | 1.00 | ALDH1A1 (0.50) | ALDH1A1ACHEGPR84FFAR1FFAR4 | |
| SCHEMBL10793332 | 1.00 | ALDH1A1 (0.50) | ALDH1A1ACHEGPR84FFAR1FFAR4 | |
| SCHEMBL4774962 | 0.98 | ALDH1A1 (0.52) | ALDH1A1ACHEGPR84FFAR1FFAR4 | |
| SCHEMBL3461348 | 0.93 | ALDH1A1 (0.54) | ALDH1A1ACHEKDM4EMEN1LMNA | |
| Ethylene Glycol SCHEMBL426064 | 0.93 | ALDH1A1 (0.54) | ALDH1A1ACHENAAAKDM4EMEN1 | |
| SCHEMBL429702 | 0.93 | ALDH1A1 (0.58) | ALDH1A1NAAAKDM4EMEN1LMNA | |
| SCHEMBL423248 | 0.93 | ALDH1A1 (0.58) | ALDH1A1NAAAKDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260026953-A1 | BALLOON DELIVERY SYSTEM FOR THE IMPLANT DEPLOYMENT | UNIV NORTHWESTERN (US) | 2026-01-29 | — | — | US | disclosed |
| US-12447239-B2 | 3D-printed bioresorbable all-polymer composite soft tissue scaffolds | NORTHWESTERN UNIVERSITY (US) | 2025-10-21 | — | — | US | disclosed |
| WO-2025091000-A1 | BIODEGRADABLE NANOCOMPOSITE INK FOR 3D PRINTING RADIOPAQUE SCAFFOLDS | NORTHWESTERN UNIVERSITY (US) | 2025-05-01 | — | — | WO | disclosed |
| US-12214104-B2 | Photo-reactive inks and thermal-curable materials made therefrom | NORTHWESTERN UNIVERSITY (US) | 2025-02-04 | — | — | US | disclosed |
| WO-2024020566-A2 | BALLOON DELIVERY SYSTEM FOR THE IMPLANT DEPLOYMENT | NORTHWESTERN UNIVERSITY (US) | 2024-01-25 | — | — | WO | disclosed |
| US-20240009357-A1 | 3D PRINTING OF BIOMEDICAL IMPLANTS | NORTHWESTERN UNIVERSITY | 2024-01-11 | — | — | US | disclosed |
| US-11850328-B2 | Body temperature-triggered, in situ forming biomaterials and devices | NORTHWESTERN UNIVERSITY (US) | 2023-12-26 | — | — | US | disclosed |
| US-11565026-B2 | 3D printing of biomedical implants | NORTHWESTERN UNIVERSITY (US) | 2023-01-31 | — | — | US | disclosed |
| US-20220133958-A1 | 3D-PRINTED BIORESORBABLE ALL-POLYMER COMPOSITE SOFT TISSUE SCAFFOLDS | NORTHWESTERN UNIVERSITY | 2022-05-05 | — | — | US | disclosed |
| US-20210008246-A1 | PHOTO-REACTIVE INKS AND THERMAL-CURABLE MATERIALS MADE THEREFROM | NORTHWESTERN UNIVERSITY (US) | 2021-01-14 | — | — | US | disclosed |
| WO-2019055656-A1 | PHOTO-REACTIVE INKS AND THERMAL-CURABLE MATERIALS MADE THEREFROM | NORTHWESTERN UNIVERSITY (US) | 2019-03-21 | — | — | WO | disclosed |
| WO-2016176444-A1 | 3D PRINTING OF BIOMEDICAL IMPLANTS | NORTHWESTERN UNIVERSITY (US) | 2016-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11850328-B2 | Body temperature-triggered, in situ forming biomaterials and devices | BMP2, LRBA, BMP1 | ALDH1A1 2559/4885ACHE 3839/4885GPR84 564/4885 |
| US-20260026953-A1 | BALLOON DELIVERY SYSTEM FOR THE IMPLANT DEPLOYMENT | SBDS, SMC3, BAG3 | ALDH1A1 4463/4885ACHE 4458/4885GPR84 2504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.